Abstract
Assessment of the therapeutic effect of neuroprotective agents requires knowledge of the natural history and structural and functional effects of individual optic neuropathies. New technologies are now available for a more accurate quantification of optic nerve and retinal nerve fiber layer topography (confocal scanning laser ophthalmoscopy and polarimetry), surface vasculature (laser Doppler flowmetry), visual acuity,visual field (SITA, high-pass resolution, SWAP, frequency doubling technology), and electrophysiologic responses (multifocal ERG, VEP).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
